Induction Chemotherapy for Locally Recurrent Rectal Cancer
Status:
Recruiting
Trial end date:
2030-03-01
Target enrollment:
Participant gender:
Summary
This is a multicentre, open-label, parallel arms, phase IIII study that randomises patients
with locally recurrent rectal cancer in a 1:1 ratio to receive either induction chemotherapy
followed by neoadjuvant chemoradiotherapy and surgery (experimental arm) or neoadjuvant
chemoradiotherapy and surgery alone (control arm)